Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1590
-0.0020 (-1.24%)
At close: Feb 13, 2026

HKG:8329 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
993.111,0421,065986.69838.811,031
Revenue Growth (YoY)
-5.76%-2.17%7.92%17.63%-18.67%-4.58%
Cost of Revenue
704.37713.66625.62543.01470.67458.93
Gross Profit
288.74328.04439.24443.68368.13572.44
Selling, General & Admin
250.08256.27343.26337.96318.65485.03
Other Operating Expenses
27.4332.744517.4511.326.83
Operating Expenses
277.25293.26391.07358.26332.38511.73
Operating Income
11.4934.7848.1885.4235.7560.71
Interest Expense
-4.86-5.08-5.57-7.03-4.6-0.83
Interest & Investment Income
3.53.656.266.478.229.22
Currency Exchange Gain (Loss)
000.050.020.030.03
Other Non Operating Income (Expenses)
-3.09-0.82-0.320.01-0.58-3.34
EBT Excluding Unusual Items
7.0432.5448.5984.938.8365.8
Impairment of Goodwill
---33.1---
Gain (Loss) on Sale of Assets
-2.94-2.89-1.01-2.64-0.58-2
Asset Writedown
--16.2-0.86-13.59
Pretax Income
4.129.6430.6782.2639.1150.21
Income Tax Expense
9.5515.8816.1518.434.811.47
Earnings From Continuing Operations
-5.4513.7714.5363.8334.3138.74
Minority Interest in Earnings
11.6211.259.6-9.481.65-2.15
Net Income
6.1725.0124.1354.3535.9636.59
Net Income to Common
6.1725.0124.1354.3535.9636.59
Net Income Growth
-80.80%3.68%-55.61%51.14%-1.73%-38.73%
Shares Outstanding (Basic)
1,6781,6781,6781,6781,6781,678
Shares Outstanding (Diluted)
1,6781,6781,6781,6781,6781,678
EPS (Basic)
0.000.010.010.030.020.02
EPS (Diluted)
0.000.010.010.030.020.02
EPS Growth
-80.81%3.68%-55.61%51.14%-1.73%-38.73%
Free Cash Flow
31.455.2838.4741.53-81.6462.32
Free Cash Flow Per Share
0.020.000.020.03-0.050.04
Dividend Per Share
0.0050.005----
Gross Margin
29.07%31.49%41.25%44.97%43.89%55.50%
Operating Margin
1.16%3.34%4.52%8.66%4.26%5.89%
Profit Margin
0.62%2.40%2.27%5.51%4.29%3.55%
Free Cash Flow Margin
3.17%0.51%3.61%4.21%-9.73%6.04%
EBITDA
38.7663.376.26114.2561.0483.55
EBITDA Margin
3.90%6.08%7.16%11.58%7.28%8.10%
D&A For EBITDA
27.2828.5228.0828.8225.2922.84
EBIT
11.4934.7848.1885.4235.7560.71
EBIT Margin
1.16%3.34%4.52%8.66%4.26%5.89%
Effective Tax Rate
232.94%53.57%52.64%22.41%12.28%22.84%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.